Investors Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,149
Closed -$1.31M 132
2021
Q4
$1.31M Buy
22,149
+1,997
+10% +$98.9K 0.61% 42
2021
Q3
$867K Buy
20,152
+318
+2% +$14.1K 0.46% 63
2021
Q2
$777K Buy
19,834
+625
+3% +$24.3K 0.42% 67
2021
Q1
$696K Buy
19,209
+1,623
+9% +$57.6K 0.41% 68
2020
Q4
$647K Buy
17,586
+198
+1% +$7.26K 0.43% 66
2020
Q3
$605K Buy
17,388
+557
+3% +$19.5K 0.45% 65
2020
Q2
$522K Buy
16,831
+3,988
+31% +$135K 0.43% 72
2020
Q1
$398K Sell
12,843
-1,254
-9% -$42.7K 0.4% 71
2019
Q4
$524K Buy
+14,097
New +$502K 0.43% 67

Other funds holding PFE

Investors Financial Group's PFE Position: Q1 2022 in Review

Investors Financial Group sold out of Pfizer (PFE) in Q1 2022, closing a stake of 22,149 shares — an estimated $1.31M sold.

Investors Financial Group first reported a position in PFE in Q4 2019 and held it in 9 quarters. The position peaked at $1.31M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Investors Financial Group reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 22,149 Pfizer shares in Q1 2022, an estimated $1.31M.
  • Investors Financial Group first reported a position in Pfizer in Q4 2019 and held it in 9 quarters.
  • Investors Financial Group's Pfizer position peaked at $1.31M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.